Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Pacira names Lee CEO, Hastings chair

Plus: CRISPR’s CMO to depart and a new CFO for Alterity

December 23, 2023 1:20 AM UTC

Pacira BioSciences Inc. (NASDAQ:PCRX) named Frank Lee CEO and a director and Paul Hastings chair, both effective Jan. 2 — the day after Chairman and CEO David Stack is set to retire.  Lee was CEO and member of the board of Forma Therapeutics Inc.; Hastings, who joined Pacira’s board in 2011, is CEO of Nkarta Inc. (NASDAQ:NKTX).

CRISPR Therapeutics AG (NASDAQ:CRSP) disclosed in an SEC filing the departure of CMO Phuong Khanh Morrow, effective Jan. 26. Morrow joined CRISPR in May 2022. The departure comes days after FDA approved the company’s Casgevy exagamglogene autotemcel, the first CRISPR-based gene editing therapy. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article